Funding Opportunities / RFPs
Currently Available Funding Opportunities / Requests for Proposals (RFPs):
Repurposing Research to Improve Patient Outcomes in Meniere’s Disease and Related Diagnoses: Clinical and Preclinical Projects: clinical repurposing trials (budgets up to $100,000) and preclinical repurposing research (budgets up to $50,000) in Meniere’s disease as well as other vertigo and hearing loss-related diagnoses, including benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis. CLOSED; SUBMISSIONS UNDER REVIEW.
APPLY FOR FUNDING:
If you’re already a ProposalCentral user, log into our new site from the top right corner.
If you don’t have a ProposalCentral login, create a login here.
Closed Funding Opportunities / Requests for Proposals (RFPs):
2022
- Drug Repurposing Clinical Trials to Impact Blood Cancers: for clinical repurposing trials testing repurposed drugs in any blood cancer from anywhere in the world – accepting budgets of up to $75,000.
- Repurposing Research to Address Diversity, Equity and Inclusion (DEI) in the Greater Chicago Area: for clinical repurposing trials from Chicagoland research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $100,000.
- US Based Clinical Repurposing Trials to Address Diversity, Equity and Inclusion (DEI): for clinical repurposing trials in any disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000.
- CureAccelerator Live! for Diversity, Equity and Inclusion (DEI) in Rare Diseases: for clinical repurposing trials in any rare disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000.
- ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): for clinical repurposing trials in any disease led by an underserved researcher in any LMIC, as defined by the World Bank – accepting budgets of up to $50,000.
2021
- Clinical Repurposing Research to Impact Veterans: repurposing clinical trials in any disease area impacting veterans, including mental health, PTSD and brain injuries – up to $50,000
- CureAccelerator Live! for Pediatric Rare Diseases: repurposing clinical trials in any pediatric rare disease – up to $50,000
- Repurposing Research to Improve Clinical Patient Outcomes in Meniere’s Disease and Related Symptoms / Consequences: repurposing clinical trials to address Meniere’s disease and symptoms / consequences of Meniere’s disease, including tinnitus and hearing loss – up to $100,000
- Preclinical Repurposing Research to Address Meniere’s Disease and Related Symptoms / Consequences: repurposing preclinical project to address Meniere’s disease and symptoms / consequences of Meniere’s disease, including tinnitus and hearing loss – up to $50,000
- Repurposing Research Led by a US-Based Racial / Ethnic Minority Principal Investigator: clinical repurposing trials in any disease led by a US-based racial / ethnic minority PI underrepresented in biomedical research, as defined by the NIH – up to $70,000
- Repurposing Research to Address Racial / Ethnic Health Disparities in the Greater Chicago Area: clinical repurposing trials from any research institution in the greater Chicago area to address racial / ethnic health disparities in communities of color as defined by the NIH – up to $80,000
- ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): clinical repurposing trials led by an underserved researcher in any LMIC, as defined by the World Bank – up to $50,000
2020
- ReGRoW Pilot: clinical repurposing research projects from PIs based in low and lower-middle income countries (LMICs) to find treatments for patients in LMICs
- Rare Blood Cancers and Retinitis Pigmentosa: clinical repurposing research projects – up to $50,000
- Meniere’s Disease: clinical repurposing research projects – up to $100,000
- Meniere’s Disease: pre-clinical repurposing research projects – up to $50,000
- Canine-Focused Comparative Trials: repurposing research projects from PIs based in North America and Europe – up to $25,000
- Chicagoland Clinical Repurposing Trials: repurposing research projects from PIs based in the Chicago area – up to $50,000